Subtle immunodeficiency in severe asthma: IgA and IgG2 correlate with lung function and symptoms

International Archives of Allergy and Immunology

Volumn 140, Issue 2, 2006, Pages 96-102

  Balzar, Silvana ^a,b   Strand, Matthew ^a,b   Nakano, Takanari ^c   Wenzel, Sally E ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Asthma; Carbohydrate antigens; IgA igG2; Mucosal protection

Indexed keywords

CARBOHYDRATE ANTIGEN; FREE LIGHT CHAIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN M; SECRETORY IMMUNOGLOBULIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTHMA; ATOPY; CLINICAL ARTICLE; CONFOUNDING VARIABLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; EOSINOPHILIA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNOCYTOCHEMISTRY; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATORY CELL; LUNG FUNCTION; LUNG LAVAGE; MALE; MAST CELL; MUCOSAL IMMUNITY; PRIORITY JOURNAL; QUESTIONNAIRE; RESPIRATORY TRACT INFLAMMATION; STEROID THERAPY; SYMPTOMATOLOGY;

ADULT; ASTHMA; BIOPSY; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN ISOTYPES; IMMUNOGLOBULIN LIGHT CHAINS; MALE; MAST CELLS; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; STATISTICS, NONPARAMETRIC;

EID: 33646539087     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092252     Document Type: Article

References (27)

1. Hamilos DL, Young RM, Peter JB, Agopian MS, Ikle DN, Barka N: Hypogammaglobulinemia in asthmatic patients. Ann Allergy 1992;68:472-481.
2. Schwartz HJ, Berger M: Intravenous gamma-globulin therapy in bronchial asthma. Allergy Asthma Proc 2002;23:15-18.
3. Kitz R, Ahrens P, Zielen S: Immunoglobulin levels in bronchoalveolar lavage fluid of children with chronic chest disease. Pediatr Pulmonol 2000;29:443-451.
4. Out TA, van de Graaf EA, van den Berg NJ, Jansen HM: IgG subclasses in bronchoalveolar lavage fluid from patients with asthma. Scand J Immunol 1991;33:719-727.
5. Oehling AG, Akdis CA, Schapowal A, Blaser K, Schmitz M, Simon HU: Suppression of the immune system by oral glucocorticoid therapy in bronchial asthma. Allergy 1997;52:144-154.
6. Kawano T, Matsuse H, Obase Y, Kondo Y, Machida I, Tomari S, Mitsuta K, Fukushima C, Shimoda T, Kohno S: Hypogammaglobulinemia in steroid-dependent asthmatics correlates with the daily dose of oral prednisolone. Int Arch Allergy Immunol 2002;128:240-243.
7. Chapel H, Geha R, Rosen F; IUIS PID (Primary Immunodeficiencies) Classification committee: Primary immunodeficiency diseases: an update. Clin Exp Immunol 2003;132:9-15.
8. Edwards E, Razvi S, Cunningham-Rundles C: IgA deficiency: clinical correlates and responses to pneumococcal vaccine. Clin Immunol 2004;111:93-97.
9. Salmun LM, Barlan I, Wolf HM, Eibl M, Twarog FJ, Geha RS, Schneider LC: Effect of intravenous immunoglobulin on steroid consumption in patients with severe asthma: a double-blind, placebo-controlled, randomized trial. J Allergy Clin Immunol 1999;103(5 Pt 1):810-815.
10. Spahn JD, Leung DY, Chan MT, Szefler SJ, Gelfand EW: Mechanisms of glucocorticoid reduction in asthmatic subjects treated with intravenous immunoglobulin. J Allergy Clin Immunol 1999;103:421-426.
11. Haque S, Boyce N, Thien FC, O'Hehir RE, Douglass J: Role of intravenous immunoglobulin in severe steroid-dependent asthma. Intern Med J 2003;33:341-344.
12. Kishiyama JL, Valacer D, Cunningham-Rundles C, Sperber K, Richmond GW, Abramson S, Glovsky M, Stiehm R, Stocks J, Rosenberg L, Shames RS, Corn B, Shearer WT, Bacot B, DiMaio M, Tonetta S, Adelman DC: A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulinfororalcorticosteroid-dependent asthma. Clin Immunol 1999;91:126-133.
13. Niggemann B, Leupold W, Schuster A, Schuster R, v Berg A, Grubl A, v d Hardt H, Eibl MM, Wahn U: Prospective, double-blind, placebo-controlled, multicentre study on the effect of high-dose, intravenous immunoglobulin in children and adolescents with severe bronchial asthma. Clin Exp Allergy 1998;28:205-210.
14. Redegeld FA, van der Heijden MW, Kool M, Heijdra BM, Garssen J, Kraneveld AD, Van Loveren H, Roholl P, Saito T, Verbeek JS, Claassens J, Koster AS, Nijkamp FP: Immunoglobulin-free light chains elicit immediate hypersensitivity-like responses. Nat Med 2002;8:694-701.
15. Wenzel SE, Schwartz LB, Langmack EL, Halliday JL, Trudeau JB, Gibbs RL, Chu HW: Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999;160:1001-1008.
16. Nakano T, Nagata A: ELISAs for free light chains of human immunoglobulins using monoclonal antibodies: comparison of their specificity with available polyclonal antibodies. J Immunol Methods 2003;275:9-17.
17. Curran-Everett D: Multiple comparisons: philosophies and illustrations. Am J Physiol Regul Integr Comp Physiol 2000;279:R1-R8.
18. Thorarinsdottir HK, Ludviksson BR, Vikingsdottir T, Leopoldsdottir MO, Ardal B, Jonsson T, Valdimarsson H, Arason GJ: Childhood levels of immunoglobulins and mannan-binding lectin in relation to infections and allergy. Scand J Immunol 2005;61:466-474.
19. Velazquez P, Wei B, Braun J: Surveillance B lymphocytes and mucosal immunoregulation. Springer Semin Immunopathol 2005;26:453-462.
20. Manson JJ, Mauri C, Ehrenstein MR: Natural serum IgM maintains immunological homeostasis and prevents autoimmunity. Springer Semin Immunopathol 2005;26:425-432.
21. Tsitoura DC, Yeung VP, DeKruyff RH, Umetsu DT: Critical role of B cells in the development of T cell tolerance to aeroallergens. Int Immunol 2002;14:659-667.
22. Stäger S, Alexander J, Kirby AC, Botto M, Rooijen NV, Smith DF, Brombacher F, Kaye PM: Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses. Nat Med 2003;9:1287-1292.
23. Ballow M: Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases. J Allergy Clin Immunol 1997;100:151-157.
24. Henz BM, Maurer M, Lippert U, Worm M, Babina M: Mast cells as initiators of immunity and host defense. Exp Dermatol 2001;10:1-10.
25. Gauchat JF, Henchoz S, Mazzei G, Aubry JP, Brunner T, Blasey H, Life P, Talabot D, Flores-Romo L, Thompson J: Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 1993;365:340-343.
26. Mellon MB, Frank BT, Fang KC: Mast cell alpha-chymase reduces IgE recognition of birch pollen profilin by cleaving antibody-binding epitopes. J Immunol 2002;168:290-297.
27. Bentley AM, Hamid Q, Robinson DS, Schotman E, Meng Q, Assoufi B, Kay AB, Durham SR: Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa. Am J Respir Crit Care Med 1996;153:551-556.